AAPL327.50+12.64 (+4.01%) ▲|ABBV244.11+1.06 (+0.44%) ▲|ABT89.27+0.94 (+1.06%) ▲|ACN137.02+2.46 (+1.83%) ▲|ADBE224.56+3.78 (+1.71%) ▲|AMAT579.43-16.27 (-2.73%) ▼|AMD529.14-18.99 (-3.46%) ▼|AMGN358.32+3.07 (+0.86%) ▲|AMT168.63-0.20 (-0.12%) ▼|AMZN254.96+7.47 (+3.02%) ▲|AVGO394.28+5.17 (+1.33%) ▲|AXP358.44+3.38 (+0.95%) ▲|BA218.12+1.01 (+0.47%) ▲|BAC61.59+0.97 (+1.60%) ▲|BKNG182.80+7.95 (+4.55%) ▲|BLK1,093.40+67.96 (+6.63%) ▲|BMY58.72+1.77 (+3.11%) ▲|BNY162.35+7.85 (+5.08%) ▲|BRK-B488.35-2.74 (-0.56%) ▼|C134.89+1.62 (+1.22%) ▲|CAT914.30-19.04 (-2.04%) ▼|CL91.47+0.44 (+0.48%) ▲|CMCSA23.49+0.30 (+1.29%) ▲|COF208.89+3.60 (+1.75%) ▲|COP111.46-0.41 (-0.37%) ▼|COST916.54-5.21 (-0.57%) ▼|CRM167.00-0.56 (-0.33%) ▼|CSCO111.77-5.32 (-4.54%) ▼|CVS105.91-0.27 (-0.25%) ▼|CVX181.60-0.16 (-0.09%) ▼|DE589.48+5.08 (+0.87%) ▲|DHR200.79+1.74 (+0.87%) ▲|DIS97.15+1.28 (+1.34%) ▲|DUK124.34-2.03 (-1.61%) ▼|EMR136.25+0.16 (+0.12%) ▲|FDX313.42-0.24 (-0.08%) ▼|GD365.63-3.87 (-1.05%) ▼|GE360.35+6.62 (+1.87%) ▲|GEV1,055.28-10.73 (-1.01%) ▼|GILD131.70+1.66 (+1.28%) ▲|GM77.64+0.77 (+1.00%) ▲|GOOG370.21+12.88 (+3.60%) ▲|GOOGL370.92+11.41 (+3.17%) ▲|GS1,152.07+12.07 (+1.06%) ▲|HD341.44+3.70 (+1.10%) ▲|HON222.84+0.16 (+0.07%) ▲|IBM211.20-5.87 (-2.70%) ▼|INTC102.99-4.77 (-4.43%) ▼|INTU279.70-2.73 (-0.97%) ▼|ISRG388.97+9.47 (+2.50%) ▲|JNJ247.02-6.83 (-2.69%) ▼|JPM346.91+4.02 (+1.17%) ▲|KO82.45-0.63 (-0.76%) ▼|LIN514.15-8.39 (-1.61%) ▼|LLY1,156.63+4.09 (+0.35%) ▲|LMT514.46-0.53 (-0.10%) ▼|LOW209.66+1.98 (+0.95%) ▲|LRCX335.43-10.67 (-3.08%) ▼|MA535.21-2.81 (-0.52%) ▼|MCD264.95-3.99 (-1.48%) ▼|MDLZ58.72-0.08 (-0.14%) ▼|MDT80.47+1.17 (+1.48%) ▲|META681.31+20.27 (+3.07%) ▲|MMM160.53+3.95 (+2.52%) ▲|MO70.52+0.36 (+0.51%) ▲|MRK123.61+2.83 (+2.34%) ▲|MS228.55+0.88 (+0.39%) ▲|MSFT395.63+10.70 (+2.78%) ▲|MU904.28-78.84 (-8.02%) ▼|NEE89.10-0.44 (-0.49%) ▼|NFLX73.68+0.15 (+0.20%) ▲|NKE42.77-0.09 (-0.21%) ▼|NOW104.73-0.12 (-0.11%) ▼|NVDA212.50+0.70 (+0.33%) ▲|ORCL132.49+4.55 (+3.56%) ▲|PEP135.40-0.05 (-0.04%) ▼|PFE24.82+0.57 (+2.35%) ▲|PG148.05+1.97 (+1.35%) ▲|PLTR133.76+0.04 (+0.03%) ▲|PM180.88+4.93 (+2.80%) ▲|QCOM177.98-0.12 (-0.07%) ▼|RTX195.89+2.50 (+1.29%) ▲|SBUX105.11-1.06 (-1.00%) ▼|SCHW102.79+1.69 (+1.67%) ▲|SO94.60-1.36 (-1.42%) ▼|SPG222.01+0.73 (+0.33%) ▲|T21.43+0.15 (+0.70%) ▲|TMO535.29+1.22 (+0.23%) ▲|TMUS187.62+0.49 (+0.26%) ▲|TSLA394.46-1.72 (-0.43%) ▼|TXN301.19-4.36 (-1.43%) ▼|UBER72.67+0.59 (+0.82%) ▲|UNH418.52-6.67 (-1.57%) ▼|UNP288.36+0.06 (+0.02%) ▲|UPS112.94-0.73 (-0.64%) ▼|USB63.01+0.87 (+1.40%) ▲|V355.14-0.88 (-0.25%) ▼|VZ42.83+0.36 (+0.85%) ▲|WFC87.51+2.22 (+2.60%) ▲|WMT112.53-1.17 (-1.03%) ▼|XOM144.51-0.58 (-0.40%) ▼|AAPL327.50+12.64 (+4.01%) ▲|ABBV244.11+1.06 (+0.44%) ▲|ABT89.27+0.94 (+1.06%) ▲|ACN137.02+2.46 (+1.83%) ▲|ADBE224.56+3.78 (+1.71%) ▲|AMAT579.43-16.27 (-2.73%) ▼|AMD529.14-18.99 (-3.46%) ▼|AMGN358.32+3.07 (+0.86%) ▲|AMT168.63-0.20 (-0.12%) ▼|AMZN254.96+7.47 (+3.02%) ▲|AVGO394.28+5.17 (+1.33%) ▲|AXP358.44+3.38 (+0.95%) ▲|BA218.12+1.01 (+0.47%) ▲|BAC61.59+0.97 (+1.60%) ▲|BKNG182.80+7.95 (+4.55%) ▲|BLK1,093.40+67.96 (+6.63%) ▲|BMY58.72+1.77 (+3.11%) ▲|BNY162.35+7.85 (+5.08%) ▲|BRK-B488.35-2.74 (-0.56%) ▼|C134.89+1.62 (+1.22%) ▲|CAT914.30-19.04 (-2.04%) ▼|CL91.47+0.44 (+0.48%) ▲|CMCSA23.49+0.30 (+1.29%) ▲|COF208.89+3.60 (+1.75%) ▲|COP111.46-0.41 (-0.37%) ▼|COST916.54-5.21 (-0.57%) ▼|CRM167.00-0.56 (-0.33%) ▼|CSCO111.77-5.32 (-4.54%) ▼|CVS105.91-0.27 (-0.25%) ▼|CVX181.60-0.16 (-0.09%) ▼|DE589.48+5.08 (+0.87%) ▲|DHR200.79+1.74 (+0.87%) ▲|DIS97.15+1.28 (+1.34%) ▲|DUK124.34-2.03 (-1.61%) ▼|EMR136.25+0.16 (+0.12%) ▲|FDX313.42-0.24 (-0.08%) ▼|GD365.63-3.87 (-1.05%) ▼|GE360.35+6.62 (+1.87%) ▲|GEV1,055.28-10.73 (-1.01%) ▼|GILD131.70+1.66 (+1.28%) ▲|GM77.64+0.77 (+1.00%) ▲|GOOG370.21+12.88 (+3.60%) ▲|GOOGL370.92+11.41 (+3.17%) ▲|GS1,152.07+12.07 (+1.06%) ▲|HD341.44+3.70 (+1.10%) ▲|HON222.84+0.16 (+0.07%) ▲|IBM211.20-5.87 (-2.70%) ▼|INTC102.99-4.77 (-4.43%) ▼|INTU279.70-2.73 (-0.97%) ▼|ISRG388.97+9.47 (+2.50%) ▲|JNJ247.02-6.83 (-2.69%) ▼|JPM346.91+4.02 (+1.17%) ▲|KO82.45-0.63 (-0.76%) ▼|LIN514.15-8.39 (-1.61%) ▼|LLY1,156.63+4.09 (+0.35%) ▲|LMT514.46-0.53 (-0.10%) ▼|LOW209.66+1.98 (+0.95%) ▲|LRCX335.43-10.67 (-3.08%) ▼|MA535.21-2.81 (-0.52%) ▼|MCD264.95-3.99 (-1.48%) ▼|MDLZ58.72-0.08 (-0.14%) ▼|MDT80.47+1.17 (+1.48%) ▲|META681.31+20.27 (+3.07%) ▲|MMM160.53+3.95 (+2.52%) ▲|MO70.52+0.36 (+0.51%) ▲|MRK123.61+2.83 (+2.34%) ▲|MS228.55+0.88 (+0.39%) ▲|MSFT395.63+10.70 (+2.78%) ▲|MU904.28-78.84 (-8.02%) ▼|NEE89.10-0.44 (-0.49%) ▼|NFLX73.68+0.15 (+0.20%) ▲|NKE42.77-0.09 (-0.21%) ▼|NOW104.73-0.12 (-0.11%) ▼|NVDA212.50+0.70 (+0.33%) ▲|ORCL132.49+4.55 (+3.56%) ▲|PEP135.40-0.05 (-0.04%) ▼|PFE24.82+0.57 (+2.35%) ▲|PG148.05+1.97 (+1.35%) ▲|PLTR133.76+0.04 (+0.03%) ▲|PM180.88+4.93 (+2.80%) ▲|QCOM177.98-0.12 (-0.07%) ▼|RTX195.89+2.50 (+1.29%) ▲|SBUX105.11-1.06 (-1.00%) ▼|SCHW102.79+1.69 (+1.67%) ▲|SO94.60-1.36 (-1.42%) ▼|SPG222.01+0.73 (+0.33%) ▲|T21.43+0.15 (+0.70%) ▲|TMO535.29+1.22 (+0.23%) ▲|TMUS187.62+0.49 (+0.26%) ▲|TSLA394.46-1.72 (-0.43%) ▼|TXN301.19-4.36 (-1.43%) ▼|UBER72.67+0.59 (+0.82%) ▲|UNH418.52-6.67 (-1.57%) ▼|UNP288.36+0.06 (+0.02%) ▲|UPS112.94-0.73 (-0.64%) ▼|USB63.01+0.87 (+1.40%) ▲|V355.14-0.88 (-0.25%) ▼|VZ42.83+0.36 (+0.85%) ▲|WFC87.51+2.22 (+2.60%) ▲|WMT112.53-1.17 (-1.03%) ▼|XOM144.51-0.58 (-0.40%) ▼|
25.9 C
New York
Thursday, July 16, 2026

Tag: development

newssourceFORcompanyinformationcontent1releasesmarket

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Broadmark Realty Capital Inc. of Class Action Lawsuit and Upcoming Deadlines...

NEW YORK, June 22, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Broadmark Realty Capital Inc. ("Broadmark"...

Pomerantz Law Firm Announces the Filing of a Class Action Against PepGen Inc. and Certain Officers – PEPG

NEW YORK, June 22, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against PepGen Inc. ("PepGen" or the "Company")...

Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers – FTRE

NEW YORK, June 22, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Fortrea Holdings, Inc. ("Fortrea" or the...

Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published...

Bagsværd, Denmark, 22 June – Today, The New England Journal of Medicine (NEJM) published results from Novo Nordisk’s phase 3 REDEFINE 1 trial evaluating the efficacy and safety of investigational CagriSema plus lifestyle interventions for weight loss in adults with obesity or overweight who have a weight-related medical complication and without diabetes.1 REDEFINE 1 met its co-primary endpoints and achieved statistically significant and clinically meaningful weight loss at 68 weeks in patients taking CagriSema versus placebo.1 These data, along with the related phase 3 REDEFINE 2 study conducted in adults with overweight or obesity and type 2 diabetes, were presented today during a scientific symposium at the American Diabetes Association’s (ADA) 85th Scientific Sessions and published in NEJM.

CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in NEJM

Data presented simultaneously at the American Diabetes Association's® 85th Scientific Sessions, showed mean weight reduction in the highest range of efficacy observed with existing...

CagriSema Demonstrates Significant Weight Loss in Adults with Obesity

Once-weekly medication results in weight loss of up to 22.7% in adults without diabetes and 15.7% in those with type 2 diabetes CHICAGO, June 22,...

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project as Federal Support for Blockchain Grows

Dr. Anosh Ahmed repurposes West Side warehouse into blockchain innovation center, targeting 250+ jobs and tech-based economic opportunities amid pro-crypto

Dr. Anosh Ahmed Advances Chicago Crypto Hub Project Amid National Pro-Crypto Policy Shift

Dr. Anosh Ahmed converts vacant West Side warehouse into blockchain innovation hub, creating 250+ jobs and advancing tech-driven economic growth aligned with Trump administration’s pro-crypto stance. 
Dr. Anosh Ahmed converts vacant West Side warehouse into blockchain innovation hub, creating 250+ jobs and advancing tech-driven economic growth aligned with Trump administration’s pro-crypto stance.

AI Integration Accelerates Mathematical Discovery Algorithms: Analyzing Computational Efficiency Gains

Artificial intelligence's capabilities have expanded across diverse domains, yet its proficiency in complex mathematical reasoning remains limited. Large language models, such as OpenAI's ChatGPT,...

New Subsidiary in Mexico: SOUEAST Debuts S06 i-DM, S07, S09, Pushes Advanced New Energy Tech

MEXICO CITY, June 22, 2025 (GLOBE NEWSWIRE) -- On June 18, 2025, at the grand brand and products launch ceremony in Centro Citibanamex, Mexico, SOUEAST announced its entry to Mexican market and unveiled three new models, attracting wide attention, signaling a significant breakthrough in SOUEAST's Latin American expansion.

SK Group and AWS Team Up to Build Cloud Computing Infrastructure to Support AI Innovation

SK Group, in partnership with AWS, will provide data center infrastructure for a new AWS AI Zone location in Ulsan that will support AI...

The American Diabetes Association Announces Winners of the Innovation Challenge to Transform Diabetes Care

This challenge Kickstarts additional investments through the new ADA Innovation Fund CHICAGO, June 21, 2025 /PRNewswire/ -- As the American Diabetes Association® (ADA) celebrates its...

BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions

Treatment with apelin receptor agonist enhanced glycemic control and demonstrated cardioprotective effects, with additive benefits observed in combination with incretin therapy

Semaglutide Increases Walking Capacity in Patients with Peripheral Artery Disease and Type 2 Diabetes

Common obesity drug reduced the risk of disease progression by 54% CHICAGO, June 21, 2025 /PRNewswire/ -- Today, a new analysis demonstrates the vascular...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsDevelopment

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers